^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    JRF103

    i
    Other names: JRF103, JRF-103
    Associations

    News

    Trials
    Company:
    Jinrui Foundation
    Drug class:
    pan-HER inhibitor
    Related drugs:
    Associations

    News

    Trials
    over1year
    An ultra-performance LC-MS/MS method for determination of JRF103 in human plasma: application in first-in-patient study. (PubMed, Bioanalysis)
    The developed method was fully validated following the international guides. The developed method was sensitive, specific and suitable for measuring JRF103 concentration in patients with advanced solid tumors in the first-in-patient study of JRF103.
    Journal
    |
    EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2) • ERBB4 (erb-b2 receptor tyrosine kinase 4)
    |
    JRF103